| 5622- | Bif, | Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice |
| - | in-vivo, | Var, | NA |
| 5623- | Bif, | Bifidobacterium breve predicts the efficacy of anti-PD-1 immunotherapy combined with chemotherapy in Chinese NSCLC patients |
| - | Study, | NSCLC, | NA |
| 5625- | Bif, | immuno, | The gut microbiome and cancer response to immune checkpoint inhibitors |
| - | Review, | Var, | NA |
| 5626- | Bif, | Bifidobacterium in anticancer immunochemotherapy: friend or foe? |
| - | Review, | Var, | NA |
| 5627- | Bif, | Efficacy and Safety of Probiotics as Adjunctive Therapy in Cancer Treatment: A Comprehensive Systematic Review and Meta-Analysis |
| - | Review, | Var, | NA |
| 5628- | Bif, | immuno, | Bifidobacterium modulation of tumor immunotherapy and its mechanism |
| - | Review, | Var, | NA |
| 5629- | Bif, | ProBio, | Gut microbiota shapes cancer immunotherapy responses |
| - | Review, | Var, | NA |
| 1250- | Bif, | Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12 |
| - | in-vitro, | SCC, | NA |
| 9201- | BITC, | Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells |
| - | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | PC, | Capan-2 | - | in-vitro, | Nor, | HPDE-6 |
| 9202- | BITC, | Inhibition of Human Breast Cancer Xenograft Growth by Cruciferous Vegetable Constituent Benzyl Isothiocyanate |
| - | in-vivo, | BC, | MDA-MB-231 |
| 9203- | BITC, | Benzyl isothiocyanate inhibits tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in a BALB/c mouse xenograft model |
| - | vitro+vivo, | BC, | 4T1 |
| - | vitro+vivo, | BC, | MDA-MB-231 |
| - | in-vitro, | CRC, | HT-29 |
| 9206- | BITC, | Inhibitory effects of benzyl isothiocyanate on the proliferation of prostate and breast cancer cells |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | LNCaP |
| 9207- | BITC, | Benzyl isothiocyanate–induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MCF-10AT |
| 9208- | BITC, | Benzyl Isothiocyanate-Induced DNA Damage Causes G2/M Cell Cycle Arrest and Apoptosis in Human Pancreatic Cancer Cells |
| - | in-vitro, | PC, | Capan-2 |
| 9209- | BITC, | ITCs, | SFN, | PEITC, | Effect of Isothiocyanates on Nuclear Accumulation of NF-κB, Nrf2, and Thioredoxin in Caco-2 Cells |
| - | in-vitro, | Colon, | Caco-2 |
| 9211- | BITC, | Apoptosis induced by benzyl isothiocyanate in gefitinib-resistant lung cancer cells is associated with Akt/MAPK pathways and generation of reactive oxygen species |
| - | in-vitro, | NSCLC, | NA |
| 9212- | BITC, | Benzyl isothiocyanate sensitizes human pancreatic cancer cells to radiation by inducing apoptosis |
| - | in-vitro, | PC, | Panc02 | - | in-vitro, | PC, | MIA PaCa-2 |
| 9162- | BITC, | Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 |
| 9210- | BITC, | Potential mechanisms of benzyl isothiocyanate suppression of invasion and angiogenesis by the U87MG human glioma cell line |
| - | vitro+vivo, | GBM, | U87MG |
| 9171- | BITC, | Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 |
| 9184- | BITC, | Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate |
| - | vitro+vivo, | BC, | NA |
| 9182- | BITC, | Benzyl isothiocyanate (BITC) triggers mitochondria-mediated apoptotic machinery in human cisplatin-resistant oral cancer CAR cells |
| - | in-vitro, | Oral, | NA |
| 9181- | BITC, | Benzyl isothiocyanate suppresses development and metastasis of murine mammary carcinoma by regulating the Wnt/β-catenin pathway |
| - | vitro+vivo, | BC, | 4T1 |
| 9179- | BITC, | Benzyl and phenethyl isothiocyanates as promising epigenetic drug compounds by modulating histone acetylation and methylation marks in malignant melanoma |
| - | in-vitro, | Melanoma, | NA |
| 9178- | BITC, | Benzyl isothiocyanates modulate inflammation, oxidative stress, and apoptosis via Nrf2/HO-1 and NF-κB signaling pathways on indomethacin-induced gastric injury in rats |
| - | in-vivo, | Nor, | NA |
| - | Study, | UTI, | NA |
| 9200- | BITC, | p53 Independent Apoptosis by Benzyl Isothiocyanate in Human Breast Cancer Cells Is Mediated by Suppression of XIAP Expression |
| - | vitro+vivo, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 9174- | BITC, | Benzyl isothiocyanate as an alternative to antibiotics? a comparative in vivo study using Pseudomonas aeruginosa |
| - | in-vivo, | Nor, | NA |
| 9172- | BITC, | Benzyl isothiocyanate induces protective autophagy in human prostate cancer cells via inhibition of mTOR signaling |
| - | in-vitro, | Pca, | PC3 |
| 9175- | BITC, | PEITC, | AITC, | Isothiocyanates in medicine: A comprehensive review on phenylethyl-, allyl-, and benzyl-isothiocyanates |
| - | Review, | Nor, | NA |
| 9170- | BITC, | p53-Independent apoptosis by benzyl isothiocyanate in human breast cancer cells is mediated by suppression of XIAP expression |
| - | in-vitro, | BC, | MCF7 |
| 9169- | BITC, | CNOT2 /c-Myc/STAT3 signaling is critically involved in glycolysis mediated apoptosis of benzyl isothiocyanate in hepatocellular carcinoma |
| - | in-vitro, | adrenal, | SK-HEP-1 | - | in-vitro, | Liver, | HUH7 |
| 9168- | BITC, | Benzyl isothiocyanate suppresses development and metastasis of murine mammary carcinoma by regulating the Wnt/β‑catenin pathway |
| - | in-vitro, | BC, | 4T1 |
| 9167- | BITC, | Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice |
| - | vitro+vivo, | BC, | 4T1 |
| 9166- | BITC, | Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/Rho-GTPases: pivotal role of STAT-3 |
| - | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | PC, | Panc02 |
| 9165- | BITC, | Anticancer activities of dietary benzyl isothiocyanate: A comprehensive review |
| - | Review, | Var, | NA |
| 9164- | BITC, | Benzyl isothiocyanate induces reactive oxygen species-initiated autophagy and apoptosis in human prostate cancer cells |
| - | in-vitro, | Pca, | 22Rv1 | - | in-vitro, | Pca, | PC3 |
| 9163- | BITC, | Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells |
| - | in-vitro, | PC, | Capan1 |
| 9186- | BITC, | Benzyl Isothiocyanate Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) Model, Which Is Associated with the Induction of Cell Cycle G1 Arrest |
| - | vitro+vivo, | Pca, | NA |
| 9199- | BITC, | Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways |
| - | in-vitro, | GC, | NA |
| 9198- | BITC, | Benzyl Isothiocyanate–Mediated Inhibition of Histone Deacetylase Leads to NF-κB Turnoff in Human Pancreatic Carcinoma Cells |
| - | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | PC, | Capan1 |
| 9197- | BITC, | Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3 |
| - | in-vitro, | BC, | NA |
| 9196- | BITC, | Benzyl Isothiocyanate Inhibits Epithelial-Mesenchymal Transition in Cultured and Xenografted Human Breast Cancer Cells |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | PC, | PL45 |
| 9195- | BITC, | Benzyl isothiocyanate inhibits prostate cancer development in the transgenic adenocarcinoma mouse prostate model |
| - | in-vivo, | Pca, | NA |
| 9192- | BITC, | Benzyl isothiocyanate: double trouble for breast cancer cells |
| - | in-vitro, | BC, | NA |
| 9190- | BITC, | Benzyl isothiocyanate suppresses high-fat diet-stimulated mammary tumor progression via the alteration of tumor microenvironments in obesity-resistant BALB/c mice |
| - | in-vivo, | BC, | 4T1 |
| 9185- | BITC, | PEITC, | AITC, | ITCs, | Effects of Brassicaceae Isothiocyanates on Prostate Cancer |
| - | Review, | Pca, | NA |
| 9187- | BITC, | Bioavailability and metabolism of benzyl glucosinolate in humans consuming Indian cress (Tropaeolum majus L.) |
| - | Study, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid